180 likes | 613 Views
“I can’t breathe”: The Challenge of Dyspnea. Comprehensive Approach to Dyspnea Management Pawandeep Brar Palliative Care Physician. Objectives. Review Non-Pharmacological Treatment of Dyspnea Review Pharmacological Treatment of Dyspnea Review Interventional Approach to Dyspnea.
E N D
“I can’t breathe”: The Challenge of Dyspnea Comprehensive Approach to Dyspnea Management PawandeepBrar Palliative Care Physician
Objectives • Review Non-Pharmacological Treatment of Dyspnea • Review Pharmacological Treatment of Dyspnea • Review Interventional Approach to Dyspnea
Electrice Fan • Simple interventions based on movement of air may relieve dyspnea for certain patients • An RCT of a hand-held electric fan directed toward the face versus toward the leg for 5 minutes showed significant decrease I dyspnea when the moving air was directed toward the face
Oxygen Therapy • Oxygen reverses dyspnea caused by hypoxemia • Limitations: many dyspneicpts are not hypoxemic • Hypoxemia is a weaker stimulus for dyspnea than hypercarbia
Pharmacological Approach: Opioids • First line of therapy for symptomatic control • Opioid Receptors in central/peripheral nervous system as well as tracheobronchial tree • Effects postulated to be secondary to their effects on ventilatory response to carbon dioxide, hypoxia, inspiratory flow resistive loading
Pharmacological Approach: Opioids • Dosing of opioids: • If opioid naïve begin with low dose of 2.5-5mg morphine equivalent q4h & titrate to effect • If on opioids, increase current dose by 20-25% & titrate to effect
Pharmacological Approach:Opioids • Concerns re Opioids • fear of respiratory depression & accelerated death • Opioids have been used for many years to decrease dyspnea • Fear has been shown to be largely unfounded
Pharmacological Approach: Benzodiazapines • Benzodiazepines are commonly prescribed for anxiety related to dyspnoea. • evidence for their effectiveness is not persuasive • treatment of anxiety does have a role in a subset of patients for whom it is a prominent component of the distress
Pharmacological Approach: Benzodiazepines • Lorazepam: 0·5–1·0 mg/h orally until settled, then dose routinely every 4–6 h to keep settled • Diazepam: 5–10 mg/h orally until settled, and then dose routinely every 6–8 h • Clonazepam: 0·25-2·00 mg orally every 12 h • Midazolam: 0·5 mg intravenously per 15 min until settled, then by continuous subcutaneous or intravenous infusion
Pharmacological Approach: Other • Glucocorticoids useful in bronchospasm, superior vena cava syndrome, carcinomatous lymphangitis and radiation pneumonitis. • Antibiotics may be appropriate for infections. • Anticoagulants can prevent and treat thrombotic pulmonary emboli. • Bronchodilators such as salbutamol and ipratropium treat reversible bronchospasm.
Complementary Approach • Counselling & support • Complementary therapies • Relaxation training • Tai chi • Yoga • Hypnosis • Therapeutic touch • accupuncture
Interventional Approach • Obstruction can be treated locally with laser therapy, cryotherapy, or stenting. • Malignant pleural effusions can be drained by thorocentesis, and if they recur, pleurodesismay be attempted. Fluid drainage may improve the mechanical advantage of the respiratory muscles to relieve dyspnoea.